欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/2923/001
药品名称Ezetimibe Mylan 10 mg
活性成分
    • ezetimibe 10.0 mg
剂型Tablet
上市许可持有人Viatris Limited Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland
参考成员国 - 产品名称Netherlands (NL)
Ezetimibe Mylan 10 mg, tabletten
互认成员国 - 产品名称
    • Germany (DE)
      Ezetimib Mylan 10 mg Tabletten
    • Denmark (DK)
    • Belgium (BE)
      Ezetimibe Viatris 10 mg tabletten
    • Luxembourg (LU)
      Ezetimibe Mylan 10 mg Comprimé
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
      EZETIMIBE/MYLAN
    • Sweden (SE)
    • Cyprus (CY)
      EZETIMIBE MYLAN TABS
    • Czechia (CZ)
      Ezetimib Mylan 10 mg, tablety
许可日期2014/05/20
最近更新日期2024/04/25
药物ATC编码
    • C10AX09 ezetimibe
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase